Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies

David A. Mankoff, Lanell M. Peterson, Timothy J. Tewson, Jeanne M. Link, Julie R. Gralow, Michael M. Graham and Kenneth A. Krohn
Journal of Nuclear Medicine April 2001, 42 (4) 679-684;
David A. Mankoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lanell M. Peterson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy J. Tewson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanne M. Link
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie R. Gralow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. Graham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Krohn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Example of TACs for FES in gallbladder (⧫), liver (▪), and blood (▴). Data are normalized to 37 MBq injected per 56 kg body weight.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    FES activity in bladder (A), gastrointestinal tract (B), and uterus (C). Different symbols are used for different studies. Data are normalized to 37 MBq injected per 56 kg body weight. Fits are shown as solid lines. Gastrointestinal tract and bladder data were fit with rising exponential (Eq. 2), and uterus data were fit with function described in Equation 3. y-axis for bladder is twice as large as for uterus and intestinal tract.

Tables

  • Figures
    • View popup
    TABLE 1

    Tissue Uptake of FES for 37-MBq Injection

    OrganNo. of studiesC̃ Mean (SD) (kBq-h/g)Organ mass (g)Ã Mean (SD) (MBq-h)
    Breast470.7 (0.3)3610.2 (0.1)
    Gall Bladder1531.7 (16.8)491.6 (0.8)
    Intestines*
     145.8 (7.0)
     214 (28)9.8
     34 plus pooled6.6 (6.4)176 (ULI) + 322 (SmI)3.3 (3.2)
    Blood482.0 (0.5)347 (heart contents)0.7 (0.2)
    Heart Wall481.8 (0.6)2410.4 (0.1)
    Kidneys34.2 (0.7)2481.0 (0.2)
    Liver4918.9 (4.8)140026.4 (6.7)
    Lungs481.3 (0.5)6510.8 (0.3)
    Red Marrow471.2 (0.6)10501.2 (0.6)
    Spleen181.1 (0.7)1230.1 (0.1)
    Bladder*
     1214.4 (10.1)
     216 (28)18.3
     32 plus pooled15.7 (7.5)1602.5 (1.2)
    Uterus*
     134.8 (2.7)
     210 (18)7.6
     33 plus pooled5.5 (2.6)790.4 (0.2)
    Remainder50,793†58.9 (7.6)
    • ↵* These organs also had additional points from more sparsely sampled TACs. 1 = fully sampled curves; 2 = pooled additional data (parentheses indicate number of points used in curve); 3 = mean of fully sampled curves plus additional value from pooled data. These numbers are used for Table 2.

    • ↵† Remainder of body for 56-kg woman.

    • ULI = large intestine; SmI = small intestine.

    • View popup
    TABLE 2

    Radiation Absorbed Dose to Organs

    OrganMean* (mGy/MBq)SD (mGy/MBq)25%† (mGy/MBq)75%† (mGy/MBq)
    Adrenals0.023  (85)0.0030.0210.025
    Brain0.010  (36)0.0010.0090.010
    Breasts0.009  (32)0.0020.0080.010
    GB wall0.102  (379)0.0410.0750.134
    LLI0.012  (45)0.0010.0110.013
    Small intestine0.027  (99)0.0150.0170.038
    Stomach0.014  (50)0.0010.0130.014
    ULI0.030  (110)0.0160.0190.042
    Heart wall0.026  (96)0.0040.0240.029
    Kidney0.035  (128)0.0040.0320.038
    Liver0.126  (466)0.0300.1050.149
    Lungs0.017  (61)0.0020.0150.018
    Muscle0.021  (79)0.0010.0210.022
    Ovaries0.018  (66)0.0020.0160.019
    Pancreas0.023  (84)0.0020.0210.024
    Red marrow0.013  (48)0.0020.0120.014
    Bone surface0.014  (53)0.0010.0140.015
    Skin0.005  (18)0.0000.0050.005
    Spleen0.015  (54)0.0030.0120.017
    Testes0.012  (44)0.0010.0110.012
    Thymus0.014  (50)0.0010.0130.014
    Thyroid0.012  (45)0.0010.0120.013
    UB wall0.050  (186)0.0200.0360.066
    Uterus0.039  (145)0.0130.0310.049
    Lens0.009  (33)0.0000.0090.009
    • ↵* Values in parentheses are mrad/mCi.

    • ↵† Determined assuming normal curve with given mean and SD.

    • GB = gallbladder; LLI = lower large intestine; ULI = upper large intestine; UB = urinary bladder.

    • Effective dose equivalent = 0.022 mSv/MBq (0.004 SD).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 4
April 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies
David A. Mankoff, Lanell M. Peterson, Timothy J. Tewson, Jeanne M. Link, Julie R. Gralow, Michael M. Graham, Kenneth A. Krohn
Journal of Nuclear Medicine Apr 2001, 42 (4) 679-684;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies
David A. Mankoff, Lanell M. Peterson, Timothy J. Tewson, Jeanne M. Link, Julie R. Gralow, Michael M. Graham, Kenneth A. Krohn
Journal of Nuclear Medicine Apr 2001, 42 (4) 679-684;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted 18F-Fluorthanatrace PET in Breast Cancer
  • Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader
  • Breast Cancer: Evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes
  • 18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications
  • Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
  • Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16{alpha}-18F-Fluoro-17{beta}-Estradiol PET/CT
  • Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16{alpha},17{alpha}-[(R)-(1'-{alpha}-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
  • PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
  • Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography
  • Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas
  • Assessment of Human Biodistribution and Dosimetry of 4-Fluoro-11{beta}-Methoxy-16{alpha}-18F-Fluoroestradiol Using Serial Whole-Body PET/CT
  • Tumor Receptor Imaging
  • Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects
  • Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
  • Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer
  • Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in Gliomas Using 18F-Fluoromisonidazole, 18F-FDG PET, and Immunohistochemical Studies
  • Seeing into cells: The promise of in vivo molecular imaging in oncology
  • 18F-Fluorothymidine Radiation Dosimetry in Human PET Imaging Studies
  • Google Scholar

More in this TOC Section

  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire